| Northwest Extremity Specialists Llc | |
|
9115 Sw Oleson Rd Ste 205, Portland, OR 97223-6877 | |
| (503) 245-2420 | |
| Not Available |
| Full Name | Northwest Extremity Specialists Llc |
|---|---|
| Type | Facility |
| Speciality | Podiatrist |
| Location | 9115 Sw Oleson Rd Ste 205, Portland, Oregon |
| Accepts Medicare Assignments | Medicare enrolled and accepts medicare insurance. Providers at this facility may prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295126241 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 213E00000X | Podiatrist | (* (Not Available)) | Primary |
| Provider Name | Thomas C Melillo |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1619085479 PECOS PAC ID: 8729071741 Enrollment ID: I20040414000811 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Jason R Surratt |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1649386541 PECOS PAC ID: 9537152558 Enrollment ID: I20040414000841 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Patricia E Cain |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1518146984 PECOS PAC ID: 8820083306 Enrollment ID: I20040415000303 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Michael V Mesa |
|---|---|
| Provider Type | Practitioner - Pathology |
| Provider Identifiers | NPI Number: 1184744351 PECOS PAC ID: 7810958956 Enrollment ID: I20041025000507 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Yama A Dehqanzada |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1154338275 PECOS PAC ID: 5698727568 Enrollment ID: I20050218000601 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Margaret B Loebner |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1700875275 PECOS PAC ID: 5193742781 Enrollment ID: I20051102000509 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Clifford D Mah |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1962454934 PECOS PAC ID: 8820091754 Enrollment ID: I20060816000043 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Julie E Horowitz |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1255517363 PECOS PAC ID: 0648331009 Enrollment ID: I20081204000453 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Brian T Horak |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1972590735 PECOS PAC ID: 6406901974 Enrollment ID: I20090904000341 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Manny Moy |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1639162795 PECOS PAC ID: 4587700885 Enrollment ID: I20090929000642 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Scott J Taylor |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1750395208 PECOS PAC ID: 4789866583 Enrollment ID: I20110316000201 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Stephen Fekete |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1356452247 PECOS PAC ID: 1951565324 Enrollment ID: I20120614000682 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Todd L Galle |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1629048533 PECOS PAC ID: 8820281975 Enrollment ID: I20130912000350 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Denny V Le |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1285977470 PECOS PAC ID: 6608173802 Enrollment ID: I20160824000558 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Mia Horvath |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1083840318 PECOS PAC ID: 8022267020 Enrollment ID: I20160907000633 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Lopa Dalmia |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1386884237 PECOS PAC ID: 8426196171 Enrollment ID: I20171101003194 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Peter D Pham |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1568877264 PECOS PAC ID: 8820350028 Enrollment ID: I20180328002281 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Lacey Beth Lockhart |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1497149454 PECOS PAC ID: 4981997194 Enrollment ID: I20191127002492 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Cara Marie Beach |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1619338829 PECOS PAC ID: 5597098103 Enrollment ID: I20200831003040 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | John Sterling Zdor |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1053830513 PECOS PAC ID: 6204102106 Enrollment ID: I20201209001991 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Meghan J Teague |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1760987234 PECOS PAC ID: 6002168697 Enrollment ID: I20210527002498 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Alexandria Mcniven |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1457927626 PECOS PAC ID: 2567865066 Enrollment ID: I20210721001985 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Lisa Sun Yoon |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1265937247 PECOS PAC ID: 4587059415 Enrollment ID: I20220311000717 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Chad Smurthwaite |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1386391852 PECOS PAC ID: 7911394143 Enrollment ID: I20220418002046 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Taylor Jacqueline Bunka |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1083119333 PECOS PAC ID: 5597154898 Enrollment ID: I20220719003068 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Melinda Sue Nicholes |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1699330803 PECOS PAC ID: 2668856238 Enrollment ID: I20220831000575 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Alexander Friedman |
|---|---|
| Provider Type | Practitioner - Orthopedic Surgery |
| Provider Identifiers | NPI Number: 1174973242 PECOS PAC ID: 9638579600 Enrollment ID: I20220906003051 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Vincent A. Gonsalves |
|---|---|
| Provider Type | Practitioner - Physical Therapist In Private Practice |
| Provider Identifiers | NPI Number: 1285808303 PECOS PAC ID: 8224409479 Enrollment ID: I20230125003090 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Provider Name | Cindy Lin |
|---|---|
| Provider Type | Practitioner - Podiatry |
| Provider Identifiers | NPI Number: 1962883579 PECOS PAC ID: 5294028411 Enrollment ID: I20230126002399 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Northwest Extremity Specialists Llc 9115 Sw Oleson Rd Ste 205, Portland, OR 97223-6877 Ph: (503) 245-2420 | Northwest Extremity Specialists Llc 9115 Sw Oleson Rd Ste 205, Portland, OR 97223-6877 Ph: (503) 245-2420 |
News Archive
Amgen today announced that the European Commission (EC) has approved a variation to the marketing authorization for Vectibix (panitumumab) to include indications for the treatment of patients with wild-type KRAS metastatic colorectal cancer (mCRC) in first-line in combination with FOLFOX and in second-line in combination with FOLFIRI in patients who have received first-line fluoropyrimidine-based chemotherapy.
The same signal that drives aggressive growth in a deadly cancer cell type also triggers coping mechanisms that make it "notoriously" hard to kill, according to a study published online December 15 in Cell. When stressed, this cell type - far more than most cancer cells - encases its genetic messages in protein globs called "stress granules" that lessen the effect of chemotherapies.
Falsehoods, rumours and conspiracy theories thrive during a crisis, and even more when the crisis revolves around a threatening disease. The combination of these two factors in a digital age is a dangerous cocktail, says a Malmö University researcher.
Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported that China's State Food and Drug Administration ("SFDA") has initiated a comprehensive investigation into quality issues regarding human use rabies vaccine (vero cell) manufactured by Simcere's subsidiary Jiangsu Yanshen Biological Technology Stock Co., Ltd. ("Jiangsu Yanshen").
Older drivers could benefit from training programs that put them behind the wheel-in a driving simulator, with an observer who helps them develop their skills. That's the conclusion of a new article published in Current Directions in Psychological Science, a journal of the Association for Psychological Science.
› Verified 3 days ago
Barnes Foot And Ankle Podiatrist Medicare: Medicare Enrolled Practice Location: 9615 Nw Randall Ln, Portland, OR 97229 Phone: 503-297-2222 | |
Edward Theodore Ysunza Iv, Podiatrist Medicare: Medicare Enrolled Practice Location: 3710 Sw Us Veterans Hospital Rd, Portland, OR 97239 Phone: 503-220-8262 | |
Dr. Brian M. Bowen, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 1717 Ne 42nd Ave, Suite 3300, Portland, OR 97213 Phone: 503-284-2000 Fax: 503-284-2002 | |
Town Center Foot Clinic Podiatrist Medicare: Medicare Enrolled Practice Location: 8305 Se Monterey Ave Ste 101, Portland, OR 97266 Phone: 503-652-1121 Fax: 503-652-2193 | |
Ray A Mcclanahan, DPM Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 725 Nw 19th Ave, Portland, OR 97209 Phone: 503-243-2699 Fax: 503-243-2698 | |
Portland Foot And Ankle Institute, Llc Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 12672 Nw Barnes Rd Ste 100, Portland, OR 97229 Phone: 503-336-0169 Fax: 503-352-4583 | |
Dr. Steven Gary Tillett, D.P.M. Podiatrist Medicare: Accepting Medicare Assignments Practice Location: 6274 Sw Capitol Hwy, Portland, OR 97239 Phone: 503-246-2212 |